Clinical trials
Terminated Lymphoma trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 3 |
| M.D. Anderson Cancer Center | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| Astex Pharmaceuticals, Inc. | 1 |
| Baylor College of Medicine | 1 |
| Brigham and Women's Hospital | 1 |
| Case Comprehensive Cancer Center | 1 |
| City of Hope Medical Center | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Indiana University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 28 |
| Leukemia | 13 |
| Lymphoma, Non-Hodgkin | 13 |
| Hodgkin Disease | 11 |
| Lymphoma, T-Cell, Cutaneous | 11 |
| Burkitt Lymphoma | 10 |
| Lymphoma, B-Cell, Marginal Zone | 10 |
| Lymphoma, Follicular | 10 |
| Lymphoma, Large B-Cell, Diffuse | 10 |
| Multiple Myeloma | 10 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.